Evidence map›Paper›PMID 38650265›Full record

ArticleBioresources and bioprocessing2021

Development of aqueous two-phase systems-based approaches for the selective recovery of metalloproteases and phospholipases A

Daniela Enriquez-Ochoa, David Meléndez-Martínez, José Manuel Aguilar-Yáñez, Cuauhtemoc Licona-Cassani, Karla Mayolo-Deloisa

Abstract read
In one paragraph

Article in Bioresources and bioprocessing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniela Enriquez-Ochoa *Tecnologico de Monterrey, School of Engineering and Sciences, Centro de Biotecnología-FEMSA, Av. Eugenio Garza Sada 2501 Sur, 64849, Monterrey, NL, Mexico.
David Meléndez-Martínez *Tecnologico de Monterrey, School of Engineering and Sciences, Centro de Biotecnología-FEMSA, Av. Eugenio Garza Sada 2501 Sur, 64849, Monterrey, NL, Mexico.
José Manuel Aguilar-YáñezTecnologico de Monterrey, School of Engineering and Sciences, Centro de Biotecnología-FEMSA, Av. Eugenio Garza Sada 2501 Sur, 64849, Monterrey, NL, Mexico.
Cuauhtemoc Licona-CassaniTecnologico de Monterrey, School of Engineering and Sciences, Centro de Biotecnología-FEMSA, Av. Eugenio Garza Sada 2501 Sur, 64849, Monterrey, NL, Mexico. clicona@tec.mx.
Karla Mayolo-DeloisaTecnologico de Monterrey, School of Engineering and Sciences, Centro de Biotecnología-FEMSA, Av. Eugenio Garza Sada 2501 Sur, 64849, Monterrey, NL, Mexico. kmayolo@tec.mx.ORCID http://orcid.org/0000-0002-2826-2518

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snake venoms are rich sources of proteins with potential biotechnological and pharmaceutical applications. Among them, metalloproteases (MPs) and phospholipases A2 (PLA

Indexed as

Aqueous two-phase systemsCrotalus molossus nigrescensMetalloproteasesPhospholipases A2RecoveryVenom

Identifiers

PMID38650265
PMCPMC10992436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.